NDC 72903-853-01
ELAHERE 5 mg/mL
MIRVETUXIMAB SORAVTANSINE · INJECTION, SOLUTION
Elahere is an intravenous injection used to treat certain types of ovarian cancer in patients whose tumors express a specific protein called folate receptor alpha. It works by delivering a cancer-fighting agent directly to cancer cells that have this protein.
Key Facts
- Brand Name
- ELAHERE
- Generic Name
- MIRVETUXIMAB SORAVTANSINE
- NDC Code (Package)
72903-853-01- NDC Code (Product)
72903-853- Manufacturer
- ImmunoGen, Inc.
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761310
- Marketing Start
- 11/14/2022
Recall History
No Recall HistoryView Full Drug Page
ELAHERE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.